ZA200904980B - Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application - Google Patents

Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application

Info

Publication number
ZA200904980B
ZA200904980B ZA200904980A ZA200904980A ZA200904980B ZA 200904980 B ZA200904980 B ZA 200904980B ZA 200904980 A ZA200904980 A ZA 200904980A ZA 200904980 A ZA200904980 A ZA 200904980A ZA 200904980 B ZA200904980 B ZA 200904980B
Authority
ZA
South Africa
Prior art keywords
application
hyperthermia
constructs
preparation
magnetic nanoparticles
Prior art date
Application number
ZA200904980A
Other languages
English (en)
Inventor
Giovanni Baldi
Franco Innocenti
Marco Bitossi
Elisabetta Ranucci
Franchini Mauro Comes
Daniele Bonacchi
Giada Lorenzi
Paolo Ferruti
Alfredo Ricci
Original Assignee
Colorobbia Italiana Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colorobbia Italiana Spa filed Critical Colorobbia Italiana Spa
Publication of ZA200904980B publication Critical patent/ZA200904980B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09C—TREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK  ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
    • C09C1/00—Treatment of specific inorganic materials other than fibrous fillers; Preparation of carbon black
    • C09C1/22—Compounds of iron
    • C09C1/24—Oxides of iron
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
    • H01F1/0036—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties showing low dimensional magnetism, i.e. spin rearrangements due to a restriction of dimensions, e.g. showing giant magnetoresistivity
    • H01F1/0045—Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use
    • H01F1/0054—Coated nanoparticles, e.g. nanoparticles coated with organic surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/05—Metallic powder characterised by the size or surface area of the particles
    • B22F1/054—Nanosized particles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/05—Metallic powder characterised by the size or surface area of the particles
    • B22F1/054—Nanosized particles
    • B22F1/056—Submicron particles having a size above 100 nm up to 300 nm
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G49/00—Compounds of iron
    • C01G49/0018—Mixed oxides or hydroxides
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G49/00—Compounds of iron
    • C01G49/02—Oxides; Hydroxides
    • C01G49/08—Ferroso-ferric oxide [Fe3O4]
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G51/00—Compounds of cobalt
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/60—Particles characterised by their size
    • C01P2004/62—Submicrometer sized, i.e. from 0.1-1 micrometer
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/60—Particles characterised by their size
    • C01P2004/64—Nanometer sized, i.e. from 1-100 nanometer
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/42—Magnetic properties

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Power Engineering (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
ZA200904980A 2006-12-18 2009-07-16 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application ZA200904980B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000328A ITFI20060328A1 (it) 2006-12-18 2006-12-18 Nanoparticelle magnetiche per applicazione in ipertermia, loro preparazione ed uso in costrutti aventi applicazione farmacologica.

Publications (1)

Publication Number Publication Date
ZA200904980B true ZA200904980B (en) 2010-05-26

Family

ID=38169993

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904980A ZA200904980B (en) 2006-12-18 2009-07-16 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application

Country Status (3)

Country Link
CN (1) CN101573142A (it)
IT (1) ITFI20060328A1 (it)
ZA (1) ZA200904980B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101797494B (zh) * 2010-03-05 2012-08-15 中国科学院上海应用物理研究所 一种磁固相分离剂及其制备方法
CN101901659A (zh) * 2010-07-30 2010-12-01 北京化工大学 一种表面修饰官能团的磁性纳米粒子的制备方法
CN111671769B (zh) * 2020-05-26 2023-02-28 赣南医学院 含铜铁氧体纳米粒子在制备抗肿瘤药物中的应用

Also Published As

Publication number Publication date
CN101573142A (zh) 2009-11-04
ITFI20060328A1 (it) 2008-06-19

Similar Documents

Publication Publication Date Title
PL2117600T3 (pl) Magnetyczne nanocząsteczki do stosowania w hipertermii, ich wytwarzanie i zastosowanie w konstruktach o zastosowaniu farmakologicznym
TWI367230B (en) Surface-modified nanoparticles, their preparation and use
EP2124550A4 (en) OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND THEIR USE
GB201008986D0 (en) A selective nickle based htdrogenation catalyst and the preparation thereof
IL194835A (en) History of cyclohexylpyrazole-lactam, an intermediate substance for their use in the preparation of drugs
EP1990337A4 (en) CHINAZOLINE DERIVATIVES, METHOD OF MANUFACTURE AND USES THEREOF
IL194266A0 (en) Anti-igf-ir antibodies and uses thereof
PL2046405T3 (pl) Biomateriały, ich wytwarzanie i zastosowanie
EP2253625A4 (en) PYRIDAZINONES, PREPARATION AND USE THEREOF
EP2236604A4 (en) ANTI-NR10 ANTIBODIES AND USE THEREOF
HK1169805A1 (en) Anti-cd22 antibodies, their immunoconjugates and uses thereof -cd22
HK1131140A1 (en) Substituted prolinamides, and the use thereof
IL213168A0 (en) 1,2,4-oxadiazole derivatives and their therapeutic use
EP1988090A4 (en) IMIDAZOLE-5-CARBOXYLIC ACID DERIVATIVES, METHOD OF MANUFACTURE AND USE THEREOF
ZA200908268B (en) 4-chloro-4-alkoxy-1,1,1-trifluoro-2-butanones, their preparation and their use in preparing 4-alkoxy-1,1,1-trifluoro-2-buten-2-ones
ZA201002307B (en) Quinazolinedione derivatives,preparation thereof and therapeutic uses thereof
IL197702A0 (en) Anti-idiotype conjugate and its use as a standard in an immunassay
HK1203206A1 (en) Antibody and use thereof
EP1961753A4 (en) DERIVATIVES OF PIRAZOLOPYRIMIDINONE, THEIR PREPARATION AND USE
IL201416A0 (en) Triazolopyridine carboxamide derivatives, preparation thereof and theraputic use thereof
EP2083828A4 (en) NORMALIZED EXTRACT AND USE THEREOF IN THE MANUFACTURE OF A MEDICINAL PRODUCT
HK1128154A1 (en) Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
IL199168A0 (en) Indolizine derivatives and the use thereof as antidiabetics
ZA200806727B (en) Functionalised nanoparticles, their production and use
ZA200903865B (en) Pyrrole derivatives, preparation and use of the same in therapy